Countstar BioMed IM1200 Automated Cell Counter

Overview

The Countstar BioMed IM1200 Automated Cell Counter is an optical image-based cell analysis system engineered for precision, reproducibility, and regulatory readiness in advanced cell therapy workflows. It employs high-resolution brightfield microscopy coupled with proprietary image segmentation algorithms to quantify viable and non-viable cells based on morphological contrast and membrane integrity—without reliance on fluorescent dyes or trypan blue staining in standard mode. Designed specifically for immunotherapy R&D and GMP-aligned process development, the IM1200 supports rapid, standardized assessment of primary human immune cells—including PBMCs, NK cells, CIK cells, DCs, TILs, and LAK cells—within physiologically relevant size ranges (2–180 µm). Its sub-20-second measurement cycle enables real-time decision-making during critical steps such as leukapheresis processing, expansion monitoring, cryopreservation qualification, and final product release testing.

Key Features

• Optimized optical path and auto-focus algorithm calibrated for low-contrast, heterogeneous immune cell suspensions—minimizing user-dependent variability in viability determination.
• Wide dynamic detection range: accurately resolves particles from small lymphocytes (≥2 µm) to large adherent-derived dendritic cells or aggregated clusters (up to 180 µm), supporting both suspension and semi-adherent cell types.
• Dual-parameter viability analysis: simultaneous quantification of concentration, viability (%), mean diameter, coefficient of variation (CV) in size distribution, and aggregation index—calculated from raw pixel-level morphology metrics.
• Integrated electronic signature module compliant with ALCOA+ principles; all user actions—including sample ID entry, parameter selection, report generation, and data export—are timestamped and linked to authenticated operator credentials.
• Centralized database architecture with role-based access control (RBAC): administrators may assign granular permissions (e.g., view-only, edit, audit, delete) across users, departments, or sites—supporting multi-lab collaboration and internal SOP enforcement.
• Traceable instrument identification: each measurement record embeds a unique device serial number and firmware revision, enabling cross-site correlation and longitudinal quality trend analysis in distributed manufacturing environments.

Sample Compatibility & Compliance

The IM1200 is validated for use with unmodified or minimally processed human primary cell suspensions, including but not limited to PBMCs isolated via Ficoll density gradient centrifugation, cytokine-activated NK/CIK cultures, and monocyte-derived DC preparations. It accommodates standard 20 µL capillary-loaded disposable slides compatible with ISO 13485-certified manufacturing. While intended solely for research use (RUO), its data management framework aligns with key elements of FDA 21 CFR Part 11 (electronic records/signatures), EU Annex 11 (computerized systems), and ICH-GCP/GLP documentation expectations—particularly through immutable audit trails, version-controlled report templates, and exportable metadata-rich outputs (PDF, Excel, JPEG).

Software & Data Management

The embedded Countstar BioMed Software Suite (v4.2+) provides a secure, locally hosted interface with encrypted local storage and optional network backup. All reports include customizable institutional headers, logo insertion fields, and configurable footers meeting internal QA documentation standards. Raw image archives, measurement logs, and operator metadata are stored in a relational SQLite database with built-in indexing by sample ID, date/time stamp, operator name, and instrument SN. Export functions support batch retrieval filtered by any combination of these parameters—facilitating retrospective analysis, CAPA investigations, and regulatory inspection readiness. USB 2.0 connectivity enables offline transfer of anonymized datasets without compromising audit trail integrity.

Applications

• Pre-infusion QC of autologous/allogeneic CAR-T, TCR-T, and NK cell products.
• Monitoring expansion kinetics and confluence thresholds during bioreactor runs.
• Assessing cryopreservation recovery rates and post-thaw viability stability.
• Standardizing donor screening protocols across clinical trial sites.
• Supporting comparability studies during process changes or facility transfers.
• Generating GLP-compliant cell banking records for IND-enabling toxicology studies.

FAQ

Is the IM1200 suitable for regulatory submissions?

The system is classified as Research Use Only (RUO); however, its data governance features—including electronic signatures, full audit trails, and traceable instrument metadata—support alignment with FDA, EMA, and PMDA expectations for analytical method documentation in early-phase clinical development.
Can it distinguish between live/dead cells without dye staining?

Yes—the default brightfield mode uses adaptive thresholding and edge-detection algorithms trained on morphological signatures of membrane integrity loss; optional trypan blue integration is available for orthogonal confirmation.
Does the software support LIMS integration?

Native HL7 and ASTM E1384-compliant export modules are available upon request; custom API access can be enabled under NDA for enterprise-level laboratory informatics deployment.
What is the recommended maintenance schedule?

Annual calibration verification using NIST-traceable microsphere standards is advised; optical path cleaning and focus calibration checks should be performed weekly per internal SOP.
Is remote technical support available?

Yes—secure remote desktop sessions with encrypted screen sharing are supported for troubleshooting, software updates, and operator training, subject to customer IT policy approval.